Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany · Delayed Price · Currency is EUR 394.20
-11.50 (-2.83%)
Jan 12, 2026, 9:51 AM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €101.18 billion as of January 12, 2026. Its market cap has increased by 0.79% in one year.
Market Cap
101.18B
Enterprise Value
92.43B
Revenue
9.99B
Ranking
n/a
PE Ratio
32.30
Stock Price
€394.20
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 101.18B, an increase of 136,843.01%. That is a compound annual growth rate of 23.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 101.18B | 3.28% |
| Dec 31, 2025 | 97.97B | -2.20% |
| Dec 31, 2024 | 100.17B | 5.60% |
| Dec 29, 2023 | 94.86B | 36.76% |
| Dec 30, 2022 | 69.36B | 41.28% |
| Dec 31, 2021 | 49.09B | -2.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.61B |
| Siemens Healthineers AG | 51.92B |
| Bayer Aktiengesellschaft | 38.29B |
| Fresenius SE & Co. KGaA | 27.63B |
| Sartorius Aktiengesellschaft | 15.76B |
| Fresenius Medical Care AG | 11.04B |
| Fielmann Group AG | 3.67B |
| Carl Zeiss Meditec AG | 3.61B |